Retrieved from Wittmer Rejuvenation Clinic
Clinicians prescribing BPC-157 should document the following in the medical record: the off-label nature of the prescription, the absence of human clinical trial data, the FDA's position on compounded BPC-157, the patient's prior treatment history with approved therapies, and the patient's written informed consent
The gastrointestinal research on BPC-157, while not directly relevant to hip injuries, reveals something important about the peptides safety profile
Dosage Guidelines by Treatment Goal Acute injury recovery: 500750mcg daily for 24 weeks Chronic condition management: 250500mcg daily for 612 weeks Gut health support: 250500mcg daily for 48 weeks General wellness and prevention: 200300mcg daily, 5 days per week Important: Always consult with a healthcare provider before starting BPC-157 therapy
Lazic R., Gabric N., Dekaris I., Bosnar D., Boban-Blagaic A., Sikiric P
Human or animal use and/or consumption is strictly prohibited by law